Younger age as a bad prognostic factor in patients with carcinoma of the cervix.

[en] Objective: To verify the influence of age on the prognosis of cervix carcinoma. Study design: Five hundred and sixty eight patients treated for a FIGO stage IB-IVA with radical irradiation in the Centre Hospitalier Universitaire Vaudois of Lausanne were subdivided according to the following age categories: _<45, 46-60, 61-69 and > 70 years. Taking the 46-60 years age group as the reference, the hazard ratios (HR) of death and corresponding 95% confidence intervals (95% CI) were estimated by means of a Cox multivariate analysis. Results: The 5-year survival rates were, respectively, 57%, 67%, 60% and 45%. For the youngest women the risk of death was significantly increased (HR = 2.00, 95% CI [1.32-3.00]) and was even more accentuated in advanced stages. Conclusion: Age under 45 years is a bad prognostic factor in carcinoma of the cervix.

Disciplines :

Oncology
Hematology

Author, co-author :

Delaloye, J-F

Pampallona, S

COUCKE, Philippe ; Centre Hospitalier Universitaire Vaudois > Radiothérapie

De Grandi, P

Language :

English

Title :

Younger age as a bad prognostic factor in patients with carcinoma of the cervix.

Publication date :

1996

Journal title :

European Journal of Obstetrics and Gynecology and Reproductive Biology

ISSN :

0301-2115

eISSN :

1872-7654

Publisher :

Elsevier Scientific, Limerick, Ireland

Peer reviewed :

Peer Reviewed verified by ORBi

Available on ORBi :

since 15 July 2009

Statistics

Number of views

73 (2 by ULiège)

Number of downloads

255 (1 by ULiège)

More statistics

Scopus citations^®

Scopus citations^®
without self-citations

OpenCitations

OpenAlex citations

Bibliography

Lindell A. Carcinoma of the uterine cervix: Incidence and influence of age. A statistical study. Acta Radiol 1952; 92 (Suppl): 1-102.
Kottmeier HL. Surgical and radiation treatment of carcinoma fo the uterine cervix. Acta Obstet Gynecol Scand 1964; 43 (Suppl 2): 1-49.
Stanhope CR, Smith JP, Wharton JT, Rutledge FN, Fletcher GH, Gallagher HS. Carcinoma of the cervix. The effect of age on survival. Gynecol Oncol 1980; 10: 188193.
Gynning I, Johnsson JE, Alm P, Tropé C. Age and prognosis in stage Ib squamous cell carcinoma of the cervix. Gynecol Oncol 1982; 15: 18-26.
Prempree T, Patanaphan V, Sewshand W, Scott RM. The influence of patients' age and tumor grade on the prognosis of carcinoma of the cervix. Cancer 1983; 51: 1764-1771.
Lybeert MLM, Meerwaldt JH, van Putten WLJ. Age as a prognostic factor in carcinoma of the cervix. Radiother Oncol 1987; 9: 147-151.
Elliott PM, Tattersall MHN, Coppleson M, Russell P, Coates AS, Solomon HJ. Changing character of cervical cancer in young women [letter]. Br Med J 1989; 298: 288.
Dattoli MJ, Gretz HF, Beller Z et al. Analysis of multiple prognostic factors in patients with stage IB cervical cancer: Age as a major determinant. Int J Radiat Oncol Biol Phys 1989; 17: 41-47.
Lee YN, Wang KL, Lin MH et al. Radical hysterectomy with pelvic lymph node dissection for treatment of cervical cancer. A clinical review of 954 cases. Gynecol Oncol 1989; 32: 135-142.
Maddux HR, Varia MA, Spann CO, Fowler WC, Rosenman JG. Invasive carcinoma of the uterine cervix in women of age 25 or less. Int J Radiat Oncol Biol Phys 1990; 19: 701-706.
Clark MA, Naahas W, Markert RJ, Dodson MG. Cervical cancer: Women aged 35 and younger compared to women aged 36 and older. Am J Clin Oncol 1991; 14: 352-356.
Kodama S, Kanasawa K, Honna S, Tanaka K. Age as a prognostic factor in patients with squamous cell carcinoma of the uterine cervix. Cancer, 1991; 68: 2481-2485.
Rutledge FN, Mitchell MF, Munsell M, Bass S, Mc Guffee V, Atkins EN. Youth as a prognostic factor in carcinoma of the cervix: a matched analysis. Gynecol Oncol 1992; 44: 123-130.
Robertson D, Fedorkow DM, Stuart GCE, Mc Gregor SE. Age as a prognostic variable in cervical squamous cell carcinoma. Eur J Gynaecol Oncol 1993; 14: 283-291.
Dodds JR, Latour JP. Relationship of age to survival rate in carcinoma of the cervix. Am J Obstet Gynecol 1961; 82: 33-36.
Decker DG, Fricke RE, Pratt JH. Invasive carcinoma of the cervix in young women. JAMA 1955; 158: 1417-1420.
Kyriakos M, Kempson RL, Perez CA. Carcinoma of the cervix in young women. Obstet Gynecol 1971; 38: 930-944.
Kjørstad KE. Carcinoma of the cervix in the young patient. Obstet Gynecol 1977; 50: 28-30.
Baltzer J, Koepcke W, Lohe KJ, Ober KG, Zander J. Age and 5-year survival rates in patients with operated carcinoma of the cervix. Gynecol Oncol 1982; 14: 220-224.
Carmichael JA, Clark DH, Moher D, Ohlke ID, Karchmar EJ. Cervical carcinoma in women aged 34 and younger. Am J Obstet Gynecol 1986; 154: 264-269.
Meanwell CA, Kelly KA, Wilson S et al. Young age as a prognostic factor in cervical cancer. Analysis of population based data from 10 022 cases. Br Med J 1988; 296: 386-391.
Spanos WK, King A, Keeney E, Wagner R, Slater JM. Age as a prognostic factor in carcinoma of the cervix. Gynecol Oncol 1989; 35: 66-68.
Junor EJ, Symonds RP, Whatson ER, Lamont DW. Survival of younger cervical carcinoma patients treated by radical radiotherapy in the West of Scotland 1964-1984. Br J Obstet Gynecol 1989; 96: 522-528.
Fyles A, Keane TJ, Barton MB, Simm J. The effect of treatment duration in the local control of cervix cancer. Radiother Oncol 1992; 25: 273-279.
Lanciano RM, Pajak TF, Martz K, Hanks GE. The influence of treatment time on outcome for squamous cell cancer of the uterine cervix treated with radiation: A patterns-of-care study. Int J Radiat Oncol Biol Phys 1993; 25: 391-397.
Girinsky T, Rey A, Roche B et al. Overall treatment time in advanced cervical carcinomas: A critical parameter in treatment outcome. Int. J. Radiat. Oncol. Biol. Phys. 1993, 27, 1051-1056.
Stata. Computing Resource Center Reference Manual, 1991
Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-481.
Greenwood M. Reports on public health and medical subjects: The natural duration of cancer. HMSO 1926; 33: 1-16.
Peto R, Pike M.C, Armitage P et al. Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. Analysis and examples. Br J Cancer 1977; 35: 1-39.
Cox DR. Regression models and life tables. J R Stat Soc B 1972; 34: 187-220.
Armitage P, Berry G. Statistical methods in medical research (2nd. ed.). Oxford: Blackwell, 1987.
Stellato G, Tikkala L, Kajanoja P. Invasive cervical carcinoma in patients ages 35 or younger. Eur J Gynaecol Oncol 1992; 13: 490-493.
Cancer incidence in five continents. IARC Scientific Publications 1992; 120: 25-30.
Sebbelov AM, Kjørstad KE, Abeler VM. Norrild B. The prevalence of human papillomavirus type 16 and 18 DNA in cervical cancer in different age groups: A study on the incidental cases of cervical cancer in Norway in 1983. Gynecol Oncol 1991; 41: 141-148.
West CML, Davidson SE, Burt PA, Hunter RD. The intrinsic radiosensitivity of cervical carcinoma: correlation with clinical data. Int J Radiat Oncol Biol Phys 1995; 31: 841.
Kerr JFR, Winterford CM., Harmon BV. Apoptosis. Its significance in cancer and cancer therapy. Cancer 1994; 73: 2013.
Levine EL, Davidson SE, Roberts SA, Chadwick CA, Potten CS, West CML. Apoptosis as predictor of response to radiotherapy in cervical carcinoma. Lancet 1994; 344: 472.
Steck KD, McDonnell TJ, El-Naggar AK. Flow cytometric analysis of apoptosis and BCL-2 in human solid neoplasms. Cytometry 1995; 20: 154-161.
Chen M, Quintans J, Thompson C, Kufe DW, Weichselbaum RR. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after after ionizing radiation, tumor necrosis factor a, and ceramide. Cancer Research 1995; 55: 991-994.
Lowe SW, Bodis S, McClatchey A et al. p53 status and the efficacy of cancer therapy in vivo. Science 1994; 266: 807-810.
Eustace D, Han X, Rowbottom A, Riches P, Heyderman E. Interleukin-6 (IL-6) function as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol 1993; 50: 15-19.
Konski A, Domenico D, Irwing D et al. Flow cytometric DNA content analysis of paraffin-embedded tissue derived from cervical carcinoma. Int J Radiat Oncol Biol Phys 1994; 30: 839-843.
Withers HR. Treatment induced accelerated human tumor-growth. Semin Radiat Oncol 1993; 3: 135-141.